These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
388 related articles for article (PubMed ID: 23508805)
21. DNA-dependent phosphorylation of Chk1 and Claspin in a human cell-free system. Clarke CA; Clarke PR Biochem J; 2005 Jun; 388(Pt 2):705-12. PubMed ID: 15707391 [TBL] [Abstract][Full Text] [Related]
22. MDC1 is a mediator of the mammalian DNA damage checkpoint. Stewart GS; Wang B; Bignell CR; Taylor AM; Elledge SJ Nature; 2003 Feb; 421(6926):961-6. PubMed ID: 12607005 [TBL] [Abstract][Full Text] [Related]
23. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control. Demidova AR; Aau MY; Zhuang L; Yu Q J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337 [TBL] [Abstract][Full Text] [Related]
24. Conserved ATRMec1 phosphorylation-independent activation of Chk1 by single amino acid substitution in the GD domain. Pereira E; Chen Y; Sanchez Y Cell Cycle; 2009 Jun; 8(11):1788-93. PubMed ID: 19411848 [TBL] [Abstract][Full Text] [Related]
25. Role for casein kinase 1 in the phosphorylation of Claspin on critical residues necessary for the activation of Chk1. Meng Z; Capalbo L; Glover DM; Dunphy WG Mol Biol Cell; 2011 Aug; 22(16):2834-47. PubMed ID: 21680713 [TBL] [Abstract][Full Text] [Related]
26. Serine-345 is required for Rad3-dependent phosphorylation and function of checkpoint kinase Chk1 in fission yeast. Lopez-Girona A; Tanaka K; Chen XB; Baber BA; McGowan CH; Russell P Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11289-94. PubMed ID: 11553781 [TBL] [Abstract][Full Text] [Related]
27. Cdk-mediated phosphorylation of Chk1 is required for efficient activation and full checkpoint proficiency in response to DNA damage. Xu N; Libertini S; Black EJ; Lao Y; Hegarat N; Walker M; Gillespie DA Oncogene; 2012 Mar; 31(9):1086-94. PubMed ID: 21765472 [TBL] [Abstract][Full Text] [Related]
28. Cleavage of claspin by caspase-7 during apoptosis inhibits the Chk1 pathway. Clarke CA; Bennett LN; Clarke PR J Biol Chem; 2005 Oct; 280(42):35337-45. PubMed ID: 16123041 [TBL] [Abstract][Full Text] [Related]
30. Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeutics. Chen Z; Xiao Z; Gu WZ; Xue J; Bui MH; Kovar P; Li G; Wang G; Tao ZF; Tong Y; Lin NH; Sham HL; Wang JY; Sowin TJ; Rosenberg SH; Zhang H Int J Cancer; 2006 Dec; 119(12):2784-94. PubMed ID: 17019715 [TBL] [Abstract][Full Text] [Related]
31. An indolocarbazole inhibitor of human checkpoint kinase (Chk1) abrogates cell cycle arrest caused by DNA damage. Jackson JR; Gilmartin A; Imburgia C; Winkler JD; Marshall LA; Roshak A Cancer Res; 2000 Feb; 60(3):566-72. PubMed ID: 10676638 [TBL] [Abstract][Full Text] [Related]
32. Damage and replication checkpoint control in fission yeast is ensured by interactions of Crb2, a protein with BRCT motif, with Cut5 and Chk1. Saka Y; Esashi F; Matsusaka T; Mochida S; Yanagida M Genes Dev; 1997 Dec; 11(24):3387-400. PubMed ID: 9407031 [TBL] [Abstract][Full Text] [Related]
33. Reconstitution of human claspin-mediated phosphorylation of Chk1 by the ATR (ataxia telangiectasia-mutated and rad3-related) checkpoint kinase. Lindsey-Boltz LA; Serçin O; Choi JH; Sancar A J Biol Chem; 2009 Nov; 284(48):33107-14. PubMed ID: 19828454 [TBL] [Abstract][Full Text] [Related]
34. Phosphorylation-dependent interactions between Crb2 and Chk1 are essential for DNA damage checkpoint. Qu M; Yang B; Tao L; Yates JR; Russell P; Dong MQ; Du LL PLoS Genet; 2012 Jul; 8(7):e1002817. PubMed ID: 22792081 [TBL] [Abstract][Full Text] [Related]
35. Spreading the signal: dissociation of Chk1 from chromatin. Smits VA Cell Cycle; 2006 May; 5(10):1039-43. PubMed ID: 16721053 [TBL] [Abstract][Full Text] [Related]
36. hHR23A is required to control the basal turnover of Chk1. Tan X; Liang RY; Chuang SM Cell Signal; 2015 Nov; 27(11):2304-13. PubMed ID: 26296656 [TBL] [Abstract][Full Text] [Related]
37. Two distinct pathways for inhibiting pds1 ubiquitination in response to DNA damage. Agarwal R; Tang Z; Yu H; Cohen-Fix O J Biol Chem; 2003 Nov; 278(45):45027-33. PubMed ID: 12947083 [TBL] [Abstract][Full Text] [Related]
38. Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy. Xiao Z; Xue J; Sowin TJ; Zhang H Mol Cancer Ther; 2006 Aug; 5(8):1935-43. PubMed ID: 16928813 [TBL] [Abstract][Full Text] [Related]
39. Regulatory interactions between the checkpoint kinase Chk1 and the proteins of the DNA-dependent protein kinase complex. Goudelock DM; Jiang K; Pereira E; Russell B; Sanchez Y J Biol Chem; 2003 Aug; 278(32):29940-7. PubMed ID: 12756247 [TBL] [Abstract][Full Text] [Related]